Canakinumab treatment of patients with hyper-IgD syndrome: An open-label, multicenter, pilot study

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2013
This article has no abstract
Epistemonikos ID: 9455b000665af946768a8ba10d4ba6bca5803dc6
First added on: Feb 05, 2025